Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Unknown 6Completed 6Recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Genitourinary 1

Conditions

Polycystic Ovary Syndrome 3Neoplasms 2Obesity 1Leukemia, Myeloid, Acute 1Hyperandrogenism 1Heart Failure 1Critical Illness 1Cardiotoxicity 1Acute Kidney Injury 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Spironolactone × Clear all
NCT05394142 2024-04-22

SPIOMET4HEALTH

Fundació Sant Joan de Déu

Phase 2 Unknown
364 enrolled

Polycystic Ovary Syndrome

NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

University of Virginia

Phase NA Unknown
20 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT04075149 2023-10-27

CBS009

University of Virginia

Phase EARLY_PHASE1 Unknown
24 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT06005259 2023-08-22

SPIROTOX

University of Sao Paulo

Phase 4 Unknown
264 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT03867682 2023-08-04

Venetoclax and Lintuzumab-Ac225 in AML Patients

Actinium Pharmaceuticals

Phase 1/2 Unknown
38 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02531412 2017-01-04

SPIROCAN

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown
24 enrolled
Genitourinary

Neoplasms, Critical Illness, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡